Genzyme Corp (GENZ)
$52.28
0.26 (+0.50%)
| CAPS Rating |
|
|---|---|
| Open | $52.06 |
| Previous Close | $52.02 |
| Daily Range | $51.35 - $52.50 |
| 52-Week Range | $47.09 - $73.75 |
| Market Cap | $13.87B |
| P/E Ratio | 28.90 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 1,390,761 |
| Average Daily Volume | 2,718,000 |
GENZ
VS S&P 500 (SPY)
How do you think GENZ will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
GENZ Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
GENZ News and Commentary
- Small and Volatile, but Not for Long – The Motley Fool
- 7 Stocks With Growth on the Menu – The Motley Fool
- The Gift That Keeps on Giving – The Motley Fool
- UPDATE 1-Genzyme 3rd-qtr profit falls on drug shortages – Reuters
- Do You Have the Guts to Buy? – The Motley Fool
- 1-Star Stocks Poised to Plunge: Human Genome Sciences? – The Motley Fool
- UPDATE 1-FDA fails to approve Clolar in adults with AML – Reuters
- Monday's Biggest Stock Stars – The Motley Fool
- Geez, Lighten Up, Mr. Market! – The Motley Fool
- Genzyme's Good News. Finally! – The Motley Fool
- UPDATE 1-Genzyme says Campath succeeds in leukemia trial – Reuters
- UPDATE 1-Genzyme sharpens drug sales view after plant woes – Reuters
- Secrets of the World's Wealthiest People – The Motley Fool
- Biomarin (BMRN) possible buyout – Blog at The Motley Fool
- Dreadful Stocks to Avoid – The Motley Fool
- Good Luck, Genzyme -- You'll Need It – The Motley Fool
- This One's Growing Through the Recession – The Motley Fool
- 5-Star Stocks on the Upswing – The Motley Fool
- 5-Star Stocks Poised to Pop: Cardiome – The Motley Fool
- 5 Stocks Geared for Growth – The Motley Fool
RSS Headlines
Fool UK
